Ultragenyx Operating Cycle from 2010 to 2026
| RARE Stock | USD 24.80 0.04 0.16% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 337.48 | Current Value 320.6 | Quarterly Volatility 142.2 K |
Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 42.9 M, Interest Expense of 76.1 M or Selling General Administrative of 388.3 M, as well as many indicators such as Price To Sales Ratio of 7.43, Dividend Yield of 0.0028 or PTB Ratio of 16.57. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
Ultragenyx | Operating Cycle | Build AI portfolio with Ultragenyx Stock |
Analyzing Ultragenyx's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Ultragenyx's current valuation and future prospects.
Latest Ultragenyx's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Ultragenyx over the last few years. It is Ultragenyx's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ultragenyx's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Ultragenyx Operating Cycle Regression Statistics
| Arithmetic Mean | 130,707 | |
| Geometric Mean | 9,731 | |
| Coefficient Of Variation | 108.79 | |
| Mean Deviation | 137,713 | |
| Median | 2,340 | |
| Standard Deviation | 142,199 | |
| Sample Variance | 20.2B | |
| Range | 276.7K | |
| R-Value | (0.87) | |
| Mean Square Error | 5.4B | |
| R-Squared | 0.75 | |
| Slope | (24,411) | |
| Total Sum of Squares | 323.5B |
Ultragenyx Operating Cycle History
About Ultragenyx Financial Statements
Ultragenyx stakeholders use historical fundamental indicators, such as Ultragenyx's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ultragenyx's assets and liabilities are reflected in the revenues and expenses on Ultragenyx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 337.48 | 320.60 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out the analysis of Ultragenyx Correlation against competitors. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Biotechnology sector continue expanding? Could Ultragenyx diversify its offerings? Factors like these will boost the valuation of Ultragenyx. Anticipated expansion of Ultragenyx directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ultragenyx data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.93) | Revenue Per Share | Quarterly Revenue Growth 0.147 | Return On Assets | Return On Equity |
Understanding Ultragenyx requires distinguishing between market price and book value, where the latter reflects Ultragenyx's accounting equity. The concept of intrinsic value - what Ultragenyx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Ultragenyx's price substantially above or below its fundamental value.
It's important to distinguish between Ultragenyx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ultragenyx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ultragenyx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.